The stock's fall snapped a four-day winning streak.

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Fintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, ...

Somerset Trust Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% in the 3rd quarter, ...

MedTech portfolio is growing at a CAGR (compounded annual growing rate) of 11%-13%. The company’s non-MedTech operations are ...

Every investor in Abbott Laboratories ( NYSE:ABT) should be aware of the most powerful shareholder groups. The group holding ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Abbott (NYSE: ABT) today announced new milstones supporting its suite of pulsed field ablation (PFA) solutions in ...

Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE: ABT) with an Outperform rating and a price ...

Abbott Laboratories closed $8.30 below its 52-week high ($121.64), which the company achieved on March 8th.

Stock analysts at Oppenheimer initiated coverage on shares of Abbott Laboratories (NYSE:ABT – Get Free Report) in a report ...